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Figure A-3. The clustal W (1.83) multiple alignments of 23 GPCRs sequences with 20 to 90% identity. 
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sp|P49684|UR2R_RAT L W Q L L A Q Y H E A M ‐ ‐ ‐ ‐ ‐ ‐ P L T P E T A R I V N Y L T T C L T Y G N S C I N P F L Y T L L
sp|Q8VIH9|UR2R_MOUSE L W Q L L A Q Y H Q A M ‐ ‐ ‐ ‐ ‐ ‐ P L T P E T A R I I N Y L T A C L T Y G N S C I N P F L Y T L L
sp|Q9UKP6|UR2R_HUMAN L W Q L L A Q Y H Q A ‐ ‐ ‐ ‐ ‐ ‐ ‐ P L A P R T A R I V N Y L T T C L T Y G N S C A N P F L Y T L L
sp|P35346|SSR5_HUMAN T V N I V N L A V A L P ‐ ‐ ‐ ‐ ‐ ‐ ‐ ‐ Q E P A S A G L Y F F V V I L S Y A N S C A N P V L Y G F L
sp|P30936|SSR3_RAT L L N I V N V V C P L P ‐ ‐ ‐ ‐ ‐ ‐ ‐ ‐ E E P A F F G L Y F L V V A L P Y A N S C A N P I L Y G F L
sp|P30935|SSR3_MOUSE L L N I V N V V C P L P ‐ ‐ ‐ ‐ ‐ ‐ ‐ ‐ E E P A F F G L Y F L V V A L P Y A N S C A N P I L Y G F L
sp|P32745|SSR3_HUMAN V L N I V N V V C P L P ‐ ‐ ‐ ‐ ‐ ‐ ‐ ‐ E E P A F F G L Y F L V V A L P Y A N S C A N P I L Y G F L
sp|O08858|SSR5_MOUSE I V N I V N L A F T L P ‐ ‐ ‐ ‐ ‐ ‐ ‐ ‐ E E P T S A G L Y F F V V V L S Y A N S C A N P L L Y G F L
sp|P30937|SSR4_RAT V V Q L L N L F V T S L ‐ ‐ ‐ ‐ ‐ ‐ ‐ ‐ D A T V N H ‐ ‐ ‐ ‐ V S L I L S Y A N S C A N P I L Y G F L
sp|P49660|SSR4_MOUSE V V Q L L N L F V T S L ‐ ‐ ‐ ‐ ‐ ‐ ‐ ‐ D A T V N H ‐ ‐ ‐ ‐ V S L I L S Y A N S C A N P I L Y G F L
sp|P31391|SSR4_HUMAN V V Q L L N L V V T S L ‐ ‐ ‐ ‐ ‐ ‐ ‐ ‐ D A T V N H ‐ ‐ ‐ ‐ V S L I L S Y A N S C A N P I L Y G F L
sp|P28646|SSR1_RAT V V Q L V N V F A E Q D ‐ ‐ ‐ ‐ ‐ ‐ ‐ ‐ D A T V S Q ‐ ‐ ‐ ‐ L S V I L G Y A N S C A N P I L Y G F L
sp|P30873|SSR1_MOUSE V V Q L V N V F A E Q D ‐ ‐ ‐ ‐ ‐ ‐ ‐ ‐ D A T V S Q ‐ ‐ ‐ ‐ L S V I L G Y A N S C A N P I L Y G F L
sp|P30872|SSR1_HUMAN V V Q L V N V F A E Q D ‐ ‐ ‐ ‐ ‐ ‐ ‐ ‐ D A T V S Q ‐ ‐ ‐ ‐ L S V I L G Y A N S C A N P I L Y G F L
sp|P35370|OPRX_RAT V F V L V Q G L G V Q P ‐ ‐ ‐ ‐ ‐ ‐ ‐ ‐ G S E T A V A I L R F C T A L G Y V N S C L N P I L Y A F L
sp|P35377|OPRX_MOUSE V F V L V Q G L G V Q P ‐ ‐ ‐ ‐ ‐ ‐ ‐ ‐ G S E T A V A I L R F C T A L G Y V N S C L N P I L Y A F L
sp|P41146|OPRX_HUMAN V F V L A Q G L G V Q P ‐ ‐ ‐ ‐ ‐ ‐ ‐ ‐ S S E T A V A I L R F C T A L G Y V N S C L N P I L Y A F L
sp|P30680|SSR2_RAT I F N V S S V S V A I S ‐ ‐ ‐ ‐ ‐ ‐ ‐ ‐ P T P A L K G M F D F V V I L T Y A N S C A N P I L Y A F L
sp|P30875|SSR2_MOUSE I F N V S S V S V A I S ‐ ‐ ‐ ‐ ‐ ‐ ‐ ‐ P T P A L K G M F D F V V I L T Y A N S C A N P I L Y A F L
sp|P30874|SSR2_HUMAN I F N V S S V S M A I S ‐ ‐ ‐ ‐ ‐ ‐ ‐ ‐ P T P A L K G M F D F V V V L T Y A N S C A N P I L Y A F L
sp|Q9R0Q2|LT4R1_RAT L V N L V E A G R T L A G W D K N S ‐ P A G Q R L K L A R Y V L I A L A F L S S S V N P V L Y A C A
sp|O88855|LT4R1_MOUSE L V N L V E A G R T V A G W D K N S ‐ P A G Q R L R L A R Y V L I A L A F L S S S V N P V L Y A C A
sp|Q15722|LT4R1_HUMAN V V N L A E A G R A L A G Q A A G L G L V G K R L S L A R N V L I A L A F L S S S V N P V L Y A C A
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Figure A-4. Interhelical interaction energies of RotScan.  Total energy and the maximum number of total 
H-bonds, middle H-bonds, and salt bridges for each helix are radically plotted in outward.  
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Figure A-5. SCREAM E of the human (top) and rat (bottom) Urotensin-II receptor.  Blue line is an 





























Figure A-6. H-bonding networks among highly conserved residues in each transmembrane (TM) from 
the cytoplasmic view (Left) and putative binding sites from the extralcellular view (Right).  
After MembScream, important residues in TMs 4 and 5 which are known as the involvement 
of the ligand binding directed more toward the binding site and final structure shows better H-











Figure A-7. The comparison of binding energies of three SB706375 analogues before (in light color) and 
after (in dark color) molecular dynamics (MD).  Relative binding energies before and after 10 ps 
quench annealing from 50 to 600 K were calculated and compared with the binding energy of 
the best case in each compound before MD which was set to 0. 
 
BE: 2.92 kcal/mol 
hKi: 8 nM, rKi: 14 nM 
BE: 9.92 kcal/mol 
hKi: 16 nM, rKi: 16 nM 
BE: -5.04 kcal/mol 
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Figure A-8. The relative binding energies from Delphi method among 20 amino acids mutant receptors 
of rat Uroteinsin II receptor complex with SB-706375 in binding mode 1 and 2 compared 
with the binding energy of wild type set to 0.  Energetically favorable mutation is shown by 

















Neutral BE (BM1) Before MD
After MD at 300K



























































Charged BE (BM2, N-)
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Figure A-9. The relative binding energies from Delphi method among mutant receptors of rat Uroteinsin 
II receptor complex with SB-706375 in Binding mode 1 (top) and 2 (bottom).  Relative binding 
energies before and after 10 ps quench annealing for charged (50 to 600 K) and neutral system 




































































































































































































































Figure A-10. Hydrophobicity penalty and Scream E of the wild type and mutant rat Urotensin-II receptor.  
The hydrophobicity penalty and Epolar energy of transmembrane (TM) 5, 6, and 7 was 
calculated and plotted radically outward in kcal/mol. In the E plot, 0 is the lowest E, and 
others are the relative E compared with the lowest one. Energetically preferred angles of each 



















Figure A-12. The calculated pKa (sulfonamide N) and solvation energies for various SB structures. 
with CH3 with CF3 With_All_Parts
Ar Ki pKa E_sol(w/ H) E_sol(minus) pKa E_sol(w/ H) E_sol(minus) pKa
1 1784 8.8 - 11.06 - 57.05 5.8 - 10.72 - 52.30 5.0
2 227 10.3 - 12.55 - 57.69 6.7 - 12.00 - 54.43 5.3
3 367 9.1 - 11.56 - 58.22 6.1 - 11.15 - 53.59 5.4
4 86 8.5 - 9.95 - 53.03 4.3 - 10.26 - 50.95 4.5
5 46 7.6 - 9.28 - 50.31 4.7 - 9.29 - 46.33 4.0





















































pKa of opted SB =  5.6
 16
* Full membrane full solvent simulations 
 
The loops and N and C termini were added, and we carried out 1 ns of MD simulations on the apo 
protein, SB706375-bound rUT2R, ACT058362-bound rat and human UT2R in explicit membrane and 
water, as shown in Figure A-14A. The root mean square deviation (RMSD) trajectory of protein and 
ligand through 1ns dynamics is given in Figure 5B, indicating that the ligand was stabilized after 100ps in 
the binding site. The reason for ligand fluctuation until 100ps is that the original H-bond of NH is in a 
quinoline ring and S2195.46 destabilized and formed an alternative H-bond with the backbone carbonyl 
atom of L2155.42. Thus, the η angle of TM5 did not converge until 100ps, as shown in Figure A-14C.  In 
particular, Figure A-15 shows the important receptor-ligand interactions in the binding site.  The starting 
structure showed several H-bonds: D1303.32 and a protonated amine in piperidine ring, S2195.46 and the 
NH in the quinoline ring, and Q2796.55 and the CO atom of the urea group. During these dynamics, water 
entered into the binding site, bridging between water and the NH of the quinoline ring thus replacing the 
H-bond of the NH quinoline with the side chain OH of S2195.46 into the backbone CO atom of L2195.42. 
Our conclusion from these full MD studies is that the MembScream predicted structure is stable. All 
classical H-bonding networks among TMs 1-2-7 (1.50-2.50-7.49) and TMs 2-3-4 (2.45-3.42-4.50) in 
rUT2R structures were stabilized through 1ns simulations.  
 
Figure A-14. Molecular dynamics simulation of ACT058362-bound rat-Urotensin II receptor in explicit 
lipid and water.  A) Final structure embedded into POPC and water, B) root mean square 
deviation (RMSD) trajectory of protein and ligand (Lig_rmsd: absolute RMSD, Lig_crmsd: 











Figure A-15. Important interaction of ACT058362 at Urotensin II receptor. A) The superimposition of 
ACT058362 at rat Urotensin II receptor before and after 1ns molecular dynamics, B) Several 
hydrogen bonding distances through 1ns dynamics.   
 
 
 
 
